← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 1997Last known activity
Sep 1, 2016
Acquired by Savara Inc. on Apr 27, 2017
Timeline
1990s
- Jun 1, 1995
Mast Therapeutics— Founded
2010s
- Apr 1, 2014
Aires Pharmaceuticals, Inc.— Acquired
- Apr 27, 2017
Savara Inc.— Acquired By
Drugs by trial phase (12 distinct, 22 trials)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (1 own, 1 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (23)
- NCT02713126CollaboratorPhase 2Sep 1, 2016
- NCT02694393CollaboratorPhase 1/Phase 2Feb 1, 2016
- NCT02646358Lead sponsorPhase 1Jan 1, 2016
- NCT02646358Study directorPhase 1Jan 1, 2016
- NCT02596477Lead sponsorPhase 2Oct 1, 2015
- NCT02596477Study directorPhase 2Oct 1, 2015
- NCT02449616Study directorPhase 3Jun 1, 2015
- NCT02449616Lead sponsorPhase 3Jun 1, 2015
- NCT02093468Lead sponsorPhase 2Jun 1, 2014
- NCT02093468Study directorPhase 2Jun 1, 2014
- NCT01737814Lead sponsorPhase 3May 1, 2013
- NCT01737814Study directorPhase 3May 1, 2013
- NCT01790087Lead sponsorPhase 1Feb 1, 2013
- NCT01790087Study directorPhase 1Feb 1, 2013
- NCT00664170Lead sponsorPhase 1Apr 1, 2008
Details
- Founded
- San Diego, CA, US Jun 1, 1995
- Last known activity
- Sep 1, 2016